在儿童瘤患者中COVID-19感染后死亡因素的元分析
Qingchen Liu1,2, Xia Wang1,3, Xueqin Zhou1,2
1People's Hospital of Fengjie, Chongqing, China.
Frontiers in oncology
|August 22, 2025
概括
这项元分析确定了COVID-19儿童癌症患者的关键死亡风险因素. 不良并发症,固体瘤和严重疾病增加了死亡率,而激进的癌症治疗显示出保护作用.
科学领域:
- 癌症学
- 传染性疾病
- 儿童医学
背景情况:
- 在儿童癌症患者中对COVID-19的研究有限.
- 对死亡风险因素的系统审查很少.
研究的目的:
- 系统分析COVID-19感染的儿童癌症患者的死亡风险因素.
- 为疫情控制和临床治疗提供基于证据的数据.
主要方法:
- 一项涉及2696名儿童癌症患者的六项观察性研究的元分析.
- 在PubMed,Embase,Cochrane图书馆和科学网上搜索相关文献.
- 使用纽卡斯尔-太华尺度评估研究质量.
主要成果:
- 不良的临床并发症,固体瘤和危急疾病显著增加死亡率 (P < 0. 05).
- 强化侵袭性癌症治疗与死亡率的降低有关.
- 放射治疗增加了死亡风险,可能是由于免疫损害;免疫治疗和手术没有显著影响预后.
结论:
- 患有COVID-19的儿童癌症患者的不良临床并发症,固体瘤和严重疾病是显著的死亡预测因素.
- 积极的癌症治疗可能会降低死亡率,但由于潜在的混因素,需要谨慎解释.
相关概念视频
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Comparing the Survival Analysis of Two or More Groups
285
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
285
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Factors Affecting the Risk of Infection
12.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.3K


